Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort
Clinical trial NCT01294540 · COMPLETED
Trial details
- NCT number
- NCT01294540
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-10-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.